PerkinElmer Inc - ESG Rating & Company Profile powered by AI
Complete ESG analysis of PerkinElmer Inc are reached by signing in. The ESG rating includes 17 UN Sustainable Development Goals including: 'Clean Water & Sanitation', 'Industry, Innovation & Infrastructure' and 'Life below Water'. Jump to the bottom of this page for potential risks for PerkinElmer Inc based on sector, geography and size.
PerkinElmer Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.7; made up of an environmental score of 4.6, social score of 5.0 and governance score of 4.6.
4.7
Medium ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
816 | Pliant Therapeutics Inc | 4.8 | High |
816 | Voyager Therapeutics Inc | 4.8 | High |
837 | PerkinElmer Inc | 4.7 | High |
837 | Bio Rad Laboratories Inc | 4.7 | High |
837 | Katakura Industries Co Ltd | 4.7 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does PerkinElmer Inc have an accelerator or VC vehicle to help deliver innovation?
Does PerkinElmer Inc disclose current and historical energy intensity?
Does PerkinElmer Inc report the average age of the workforce?
Does PerkinElmer Inc reference operational or capital allocation in relation to climate change?
Does PerkinElmer Inc disclose its ethnicity pay gap?
Does PerkinElmer Inc disclose cybersecurity risks?
Does PerkinElmer Inc offer flexible work?
Does PerkinElmer Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does PerkinElmer Inc disclose the number of employees in R&D functions?
Does PerkinElmer Inc conduct supply chain audits?
Does PerkinElmer Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does PerkinElmer Inc conduct 360 degree staff reviews?
Does PerkinElmer Inc disclose the individual responsible for D&I?
Does PerkinElmer Inc disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does PerkinElmer Inc disclose current and / or historical scope 2 emissions?
Does PerkinElmer Inc disclose water use targets?
Does PerkinElmer Inc have careers partnerships with academic institutions?
Did PerkinElmer Inc have a product recall in the last two years?
Does PerkinElmer Inc disclose incidents of discrimination?
Does PerkinElmer Inc allow for Work Councils/Collective Agreements to be formed?
Has PerkinElmer Inc issued a profit warning in the past 24 months?
Does PerkinElmer Inc disclose parental leave metrics?
Does PerkinElmer Inc disclose climate scenario or pathway analysis?
Does PerkinElmer Inc disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does PerkinElmer Inc disclose the pay ratio of women to men?
Does PerkinElmer Inc support suppliers with sustainability related research and development?
Does PerkinElmer Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does PerkinElmer Inc reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is PerkinElmer Inc involved in embryonic stem cell research?
Does PerkinElmer Inc disclose GHG and Air Emissions intensity?
Does PerkinElmer Inc disclose its waste policy?
Does PerkinElmer Inc report according to TCFD requirements?
Does PerkinElmer Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does PerkinElmer Inc disclose energy use targets?
Does PerkinElmer Inc disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does PerkinElmer Inc have a policy relating to cyber security?
Have a different question?
Potential Risks for PerkinElmer Inc
These potential risks are based on the size, segment and geographies of the company.
PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment offers a suite of solutions, including reagents, informatics, and detection and imaging technologies that enable scientists to enhance research breakthroughs in the life sciences research market, as well as contract research and laboratory services. It also provides analytical technologies, solutions, and services for the environmental, food, and industrial markets that enable its customers to understand the characterize the health of various aspects, including air, water, and soil. In addition, this segment offers solutions to farmers and food producers; and analytical instrumentation for the industrial market, which includes the chemical, semiconductor and electronics, energy, lubricant, petrochemical, and polymer industries. The Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies. PerkinElmer, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.